Back
Cabana Target Leading Sector Moderate ETF Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
38
CLSM
Cabana Target Leading Sector Moderate ETF
Last Price:
$20.09
Seasonality Move:
-3.54%
Sell
45
DRUG
Bright Minds Biosciences
Last Price:
$35.96
Seasonality Move:
-28.52%
Sell
38
Cabana Target Leading Sector Moderate ETF (CLSM)
is a Sell
Is Cabana Target Leading Sector Moderate ETF a Buy, Sell or Hold?
-
The current Cabana Target Leading Sector Moderate ETF [CLSM] share price is $20.05. The Score for CLSM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
CLSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $34.34. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLSM Stock Price Chart
What is Cabana Target Leading Sector Moderate ETF's stock price today?
-
The Cabana Target Leading Sector Moderate ETF share price today is $20.05Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLSM is experiencing slight selling pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $34.34Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
CLSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 35.64 | Sell |
Chaikin Money Flow: | -10297 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.47 - 21.09) | Sell |
Bollinger Bands (100): | (20.61 - 21.65) | Sell |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.96 | Sell |
Relative Strength Index (14 RSI): | 45.83 | Sell |
Chaikin Money Flow: | 19166 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.91 - 42.27) | Sell |
Bollinger Bands (100): | (32.26 - 45.88) | Sell |
CLSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.43 | Sell |
20-day SMA: | 20.75 | Sell |
50-day SMA: | 20.72 | Sell |
200-day SMA: | 21 | Sell |
8-day EMA: | 20.41 | Sell |
20-day EMA: | 20.63 | Sell |
50-day EMA: | 20.81 | Sell |
200-day EMA: | 20.88 | Sell |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.86 | Sell |
20-day SMA: | 37.71 | Sell |
50-day SMA: | 37.1 | Sell |
200-day SMA: | 20.1 | Buy |
8-day EMA: | 35.01 | Sell |
20-day EMA: | 36.11 | Sell |
50-day EMA: | 36.53 | Sell |
200-day EMA: | 24.85 | Buy |
Cabana Target Leading Sector Moderate ETF Earnings Growth & CLSM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.84 per share, and a decrease next year of $1.29 per share.
Cabana Target Leading Sector Moderate ETF Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |